These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 14736669)
1. Role of CT in the management of recurrent ovarian cancer. Funt SA; Hricak H; Abu-Rustum N; Mazumdar M; Felderman H; Chi DS AJR Am J Roentgenol; 2004 Feb; 182(2):393-8. PubMed ID: 14736669 [TBL] [Abstract][Full Text] [Related]
2. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649 [TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Tebes SJ; Sayer RA; Palmer JM; Tebes CC; Martino MA; Hoffman MS Gynecol Oncol; 2007 Sep; 106(3):482-7. PubMed ID: 17590420 [TBL] [Abstract][Full Text] [Related]
4. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer. Qayyum A; Coakley FV; Westphalen AC; Hricak H; Okuno WT; Powell B Gynecol Oncol; 2005 Feb; 96(2):301-6. PubMed ID: 15661212 [TBL] [Abstract][Full Text] [Related]
6. Ovarian carcinomatosis: how the radiologist can help plan the surgical approach. Nougaret S; Addley HC; Colombo PE; Fujii S; Al Sharif SS; Tirumani SH; Jardon K; Sala E; Reinhold C Radiographics; 2012 Oct; 32(6):1775-800; discussion 1800-3. PubMed ID: 23065169 [TBL] [Abstract][Full Text] [Related]
7. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer]. Li YF; Li MD; Liu FY; Liu JH; Li JD Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651 [TBL] [Abstract][Full Text] [Related]
8. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer. Munkarah A; Levenback C; Wolf JK; Bodurka-Bevers D; Tortolero-Luna G; Morris RT; Gershenson DM Gynecol Oncol; 2001 May; 81(2):237-41. PubMed ID: 11330956 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of computed tomography in predicting cytoreductive surgical outcomes for ovarian cancer. Fujwara K; Yoshino K; Enomoto T; Fujita M; Ueda Y; Miyatake T; Kimura T; Muraji M; Fujita H; Kimura T; Hori M Arch Gynecol Obstet; 2011 Dec; 284(6):1501-7. PubMed ID: 21347681 [TBL] [Abstract][Full Text] [Related]
10. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings. Kim HJ; Choi CH; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG Taiwan J Obstet Gynecol; 2014 Sep; 53(3):343-7. PubMed ID: 25286788 [TBL] [Abstract][Full Text] [Related]
11. Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery. Lakhman Y; Akin O; Sohn MJ; Zheng J; Moskowitz CS; Iyer RB; Barakat RR; Sabbatini PJ; Chi DS; Hricak H AJR Am J Roentgenol; 2012 Jun; 198(6):1453-9. PubMed ID: 22623562 [TBL] [Abstract][Full Text] [Related]
12. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368 [TBL] [Abstract][Full Text] [Related]
13. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT. Kim CK; Park BK; Choi JY; Kim BG; Han H J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348 [TBL] [Abstract][Full Text] [Related]
14. Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer. Paik ES; Lee YY; Kim TJ; Choi CH; Lee JW; Kim BG; Bae DS J Gynecol Oncol; 2016 May; 27(3):e24. PubMed ID: 27029745 [TBL] [Abstract][Full Text] [Related]
15. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Dowdy SC; Mullany SA; Brandt KR; Huppert BJ; Cliby WA Cancer; 2004 Jul; 101(2):346-52. PubMed ID: 15241833 [TBL] [Abstract][Full Text] [Related]
16. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. Nelson BE; Rosenfield AT; Schwartz PE J Clin Oncol; 1993 Jan; 11(1):166-72. PubMed ID: 8418230 [TBL] [Abstract][Full Text] [Related]
17. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Bristow RE; del Carmen MG; Pannu HK; Cohade C; Zahurak ML; Fishman EK; Wahl RL; Montz FJ Gynecol Oncol; 2003 Sep; 90(3):519-28. PubMed ID: 13678719 [TBL] [Abstract][Full Text] [Related]
18. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma]. Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335 [TBL] [Abstract][Full Text] [Related]
19. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome. Salani R; Santillan A; Zahurak ML; Giuntoli RL; Gardner GJ; Armstrong DK; Bristow RE Cancer; 2007 Feb; 109(4):685-91. PubMed ID: 17219441 [TBL] [Abstract][Full Text] [Related]
20. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]